GSK's Potential Blockbuster Asthma Drug Shows Promise in Lat

By Najat Kantouar and Helena Smolak


GSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than 3 billion pounds ...

Related Keywords

United Kingdom , British , Helena Smolak , Emma Walmsley , Najat Kantouar , Aiolos Bio , Pfizer , Chief Executive Emma Walmsley , Dow Jones ,